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A protein (ERGO) with sequence similarity IO phosphoinositide-specific phospholipase C-a purifibxi from rat liver cndoplasmic reticulum (ER) 
degraded ER resident proteins and is really a protease [(1992) I. Biol. Chem. 2G5, 15152-15159]. Therefore, ER60 is called ER-60 protease. We 
now show that negatively charged phospholipids, phosphatidylinositol, phosphatidylinositol 4.5-bisphosphate and phosphatidylserinc i hibit ER 
protein degradation by ER-60 protcas-e. Phosphatidylcholine and phosphatidylcthanolamineshow n  elTeTecl on the activity of ER-69 protease. With 
the USC of protez,e inhibitors, ER-60 proteasc is shown to bc a novel cysteinc protease distinct from those of the cy~osol and lysosomes. 
Endoplasmic reticulum; Cysteinc prolease; Phospholipid; ER-GO protease; Rat 
1. INTRODUCTION 
A nulnber of proteins synthesized on the rough endo- 
plasmic reticu!um (ER) is properly folded and assem- 
bled into oligomers in the lumen of ER, and then sorted 
to organellcs. However, proteins with improper struc- 
tures, are known to be degraded in a pre-Golgi compart- 
ment [I]. Unassembled or partially assembled com- 
plexes of the T cell antigen receptor (TCR), which is 
composed of at least seven subunits, are selectively de- 
graded in E1C after their de novo synthesis [2-4]. Other 
unassembled subunits of oligoi=eric proteins [5,6] and 
abnormal proteins [7&J were also observed to be 
degraded. 3-Hydroxy-3-methylglutaryl coenzyme A 
(HMG-CoA) reductase which is an ER resident protein 
is also degraded in a pre-Golgi compartment through 
a metabolically controlled pathway [9]. 
Such ER protein degradation has been thought to be 
catalyzed by cysteine protease( since it is inhibited by 
cysteine protease inhibitors and sulfhydryl reagents [ 1 O- 
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I I?]. Recently, we have purified phosphoinositide-spe- 
cific phospholipase C-a family (ERGO), one of the ER 
resident proteins [13], which degrades other ER resident 
proteins such as protein disulfide-isomerase and cal- 
reticulin. Therefore, we call ER60 ER-60 protease. In 
this paper, we report that ER protein degradation by 
ER-60 protease may be controlled by acidic phosphol- 
ipids including phosphoinositides. 
2. EXPERIMENTAL 
2.1 Murerfais 
Dilinoleoyl phosphatidylcholine (PC), dilinolrwyl phosphatidylo 
thanolnminc (PEI and bovine liver phospb.atidylinositol (PI) svere pur- 
chased from Avanti Polar-Lipids Inc., Alabama. Phosphatidylinosid 
4,5-bisphosphatc (PIP3 and bovine brain phospl-zxtidylxrine (PS) 
were purchased from Signa. N-Acetyl-leucyl-leucyl-norlcucinal 
(ALLN) and Ibr_a,tyl-lcucyl-lcucyi-methioninal (ALLM) were from 
Boehringcr Mannheim. IV-Tosyl+iysyl chloromethyl ketone (TLCK) 
was from Aldrich Chcm. Co. N-Tosyl-L-phcnylalanyl chloromethyl 
ketone (TPCK) was obtaincul from Nxalai Tcsque Inc., Kyoto, 
Japan. Leupeptin and E-64 were purchased from Pcptidc Institute, 
Inc., Osaka, Japan, Bovine liver protein disulfide-isomerase was ob- 
tuined from Takara Shuzo Co. Ltd., Kyoto, Japan. 
2.2. Proreiti prepurarims 
Male Sprague-Dawley rats (8 weeks old) were used to prepare the 
rough ER fraction by differential centrifupation. as described previ- 
ously [13]. ER-60 protease and calrcticulin were purified from the 
rough ER fraction through three sequential chromato&raphies, on 
DEAE Toyopearl 650, AF-heparin Toyopearl 650M and TSK Be1 
G30OOSW, 2s dcxribed previously [13]. 
2.3. Assaying of prolcolytfc degradation 
The purified ER-60 protease which is composed of eight sub-species 
1131 was dialyzed overnight at 4*C ag;linst 10 mM his-Tris/f-ICI. pH 
7.0. Bovine protein disulfidc-isomcrase (2pg of prolcin) or rdt czdrctic- 
ulin (2 pg of protein) and ER-60 protcasc {i ~1 of pU.hj w*rG 
incubated for the indicated times at 37OC in 40 mM his-Tris/MCI, pH 
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6.3, supplemented with 0.1 M ,%mercaptocthanol in the presence or 
absence of an inhibitor or phospholipids, in a final VOlUlnC of 9 PI. 
Phospholipids were sonicatcd for 3 min in 100 mM bis-Tris/HCI, pH 
6.3, and then added to the reaction mixture. The reaction products 
were analyzed by sodium dodecyl sulfate-polyactylamide gelelecvo- 
phoresis (SDS-PAGE). 
2.4. Misceilattcotrs 
Protein concentrations were determined using a protein assay kit 
from Rio-Rad, with y-globulin as a standard. 
SDS-PAGE was performed according to the method of Lacmmli 
[I41 using 12.5% acrylamide under reducing conditions. The proteins 
were stained with Coomassic brilliant blue R-250. 
3. RESULTS AND DISCUSSION 
ER-60 protease has properties like those of other 
neutral cystcinc protease [13] and is composed of an 
amino acid sequence similar to that of phosphoinosi- 
tide-specific phospholipase C-a of rat basophilic Icu- 
kaemia cells [15]. In addition, we observed that the 
amino acid sequence Dam Asn”” to Pro”” near the 
carboxy- terminus exhibits 56% similarity to the amino 
acid sequence from GIL?’ to Ala” of human lipoprotein 
A-2 [16] (Fig. 1). Lipoprotein A-2, one of the high den- 
sity lipoproteins, forms an amphipathic a-helical struc- 
ture and associates with phospholipids [17]. With this 
similarity we considered that, phospholipids might be 
expected to interact with ER-60 protease and influence 
the proteolytic activity. Among the phospholipids ex- 
amined, PI, PIP, and PS inhibited the degradation of 
protein disulfide~isomerase nd calrcticulin by ER-60 
protease partially at 5OpM (Fig. 2A and 6, lanes 9, 12 
and 15) and completely above 200 PM (lanes 10, 11, 13, 
14, 16 and 17), under the conditions that protein disul- 
fide-isomerase and calreticulin were cleaved to produce 
new peptide fragments after 3-h and lo-min incubation 
(Fig. 2A and B, lanes 3 and 4). The inhibition by acidic 
phospholipids appeared not to be caused by trapping 
Ca2+ by these phospholipids, since ERGO protease was 
not inhibited by EGTA (Fig. 4A and B, lane 11). Nei- 
ther PC nor PE affected the degradation (Fig. 2A and 
B, lanes 5, 6, 7 and 8). However, ER-60 protease, pro- 
tein disulfide isomerase or calreticulin itself was not 
autocatalytically degraded even after 3 h (Fig. 2A and 
B, lanes 1 and 2). After incubation of ER-60 protease 
with PE, the band of ER-60 protease on the SDS-PAGE 
plate looked smeared. This suggests appreciable inter- 
action between PE and ER-60 protease. PI in liposomes 
comprising PC and PE (2:l) inhibited the degradation 
of protein disulfide-isomerase by ER-60 protease in a 
concentration- dependent fashion (Fig. 3). PI and PS 
comprise about 13% and 5% of the total phospholipids 
of ER [lS]. PI is distributed symmetrically between the 
two halves of ER membranes [ 191. Possibly, ER-60 pro- 
tease binds to the cisternal side of the ER through its 
interaction with phospholipids, similar to lipoprotein 
A-2, Hence, it may be that most of its proteolytic activ- 
ity in situ is inhibited by acidic phospholipids and thus 
remains latent. There is no direct evidence of the associ- 
ation of ER-60 protease with the inner half layer of 
ER-membranes, Localization of ER-60 protease using 
immunogold particles indicates that almost all of the 
gold particles are localized in the ER lumen, but some 
gold particles were observed on the ER membranes by 
immunoelectron microscopy [133. 
As to the protein degradation systems in animal cells, 
lysosomal and cytosolic proteases are well characterized 
[20], and we have characterized ER-60 protease as a 
cysteine protease by using protease inhibitors [13]. 
When the reaction mixtures were treated under the con- 
ditions (37OC, 3 h) that protein disulfide-isomerase and 
calreticulin were well degraded in the absence of’ inhib- 
itors (Fig. 4A and B, lane 2), the degradation of both 
proteins by ER-60 protease was inhibited by ALLN, 
ALLM, leupeptin and E-64 (lanes 3, 4, 7 and S), which 
are known to inhibit cathepsins B, H and L, and cal- 
pains, all cysteine proteases. Neither TLCK nor TPCK 
inhibited ER-60 protease (Fig. 4A and B, lanes 5 and 
6) indicating that it is not a cathepsin-type protease 
since TPCK and TLCK inhibit cathepsins B and L 
[21,22]. In addition, EGTA, which inhibits the prote- 
olytic activity of calpains [233, did not inhibit the ER-60 
protease (Fig. 4A and B, lane 11). o-Phenanthrolinc, 
which is a metallo protease inhibitor, did not inhibit the 
degradation (data not shown). The degradation of pro- 
tein disulfide-isomerase and calreticulin by ER-60 pro- 
tease optimally occurred at pH 6.3, and did noi proceed 
below pH 5 or above pH 7.3 (data not shown). This 
pH-activity relationship is different from those of 
cathepsins B and L, which are more acidic [20,22-241, 
and that of calpains, which is more alkaline [25]. In 
addition, the amino acid sequence of ER-60 protease is 
not homologous to those of any known proteases, in- 
cluding cellular cysteine proteases. These results may 
indicate that ER-60 protease is a new type of cysteine 
protease which is localized in ER and may be regulated 
by acidic phospholipids including phosphoinositides. 
It has been reported that ER protein degradation is 
catalyzed by cysteine protease [ 1 O-l 21. The degrada- 
tion of TCR-a and HMG-CoA reductase is inhibited by 
ALLN. However, TPCK inhibited the degradation of 
PIPLC-Cl 430487 NDVPSDYi'VKGFPTfYFSPA~KKLTPKKYEGQRRLNDFISYL~REATNPP 
. : :: :. . . :: *:: -** . . 
ape A-2 27-75 EKVKSP-eLPAQAKSYFEK~K~~~~~L~KK~~T~LV~~~~~FV~L~~~~~ 
Fig. I. Amino acid sequence alignment of phosphoinositidr-specific phospholipdse C-a (PIPLC-a) with human lipoprotein A-2 (apo A-2). The 
region of similarity between residues 438-487 of PIPLC-a [IS] and residues 27-75 of apo A-2 [16] is shown. Double dots indicate identical amino 
acids. Single dots indicate amino acids v+ith similar physicocltemical properties. 
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Fig. 2. Etkts of phospholipids on the protealytic activity of ERdO protease. Protein disulfidc+omcrasc (PDI) (A) and calrcticulin (CAL) (8) 
were incubated without (lane 2) or with ER-60 proteasc (lanes 3-17) in the absence (lanes 3 and 4) or presence of 200 yM PC (lane 5). SOOpM 
PC (lane G), 200 ,uM PE (lane 7), 500 ,uM PE (lane i?), 50 yM PS (lane 9), 200 &M PS (lane 10). 500 ,uM PS (lane II). 50 PM PI (lane 12). 200 
,BM Pl (lane 131, SOOpM PI (lane 14), 50 PM PIP, (lane 1% 200 PM PIP2 (lane 16) or 500,uM PIP, (lane 17) at 37°C for 10 min (A) or 20 min 
(8) except hat the reactions proceeded for 3 h (lanes 2 and 3), PS dcscri!red under Expcrimcntal. Then the samples were subjected to SDS-PAGE. 
Lane 1 contained ER-60 protease (I ~16 cf protein) incubated at 37% for 3 h. 
TCR-a but not that of HMG-CoA reductasi: i26i. This 
suggests that lnore than one type of cysteine protease 
may participate in ER protein degradation. It has been 
shown that incorporation of basic or acidic amino acid 
residues into the central positions of transmembrane 
segments of proteins causes ER proteins to be degraded 
more rapidly 127,281. It is interesting that the cleavage 
sites of the proteins attacked by ER-60 protease inc!ude 
a basic amino acid [ 133. 
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Fig. 3. Inhibition of the proteolytic activity of ER-60 protease by PI 
in PUPE liposomes. Protein disulfide~isomerase (PDI) was incubated 
without (lane 1) or with RR-GO prolease (lanes 2-13) in the absence 
(lanes 2-4) or presence of 300yM PC and 150pM PE (lanes 5-7), 30U 
PM PC, l5OyM PE and 50kM Pi (lanes &IO), or 300,~M PC, IS0 
piti PE and 2tX pM Pi (hb3 i l-13) Zi 37°C fOi 13 air ‘+I+ 7 5 A , YA -.I _, , 
8 and I I), 30 min (lanes 3,6.9 and 12) or 60 min (lanes I, 4,7, 10 and 
13), as dcscribcd under Experimental. Then the samples were sub- 
jected to SDS-PAGE. 
At present, there is little evidence to support the con- 
nection between PI metabolism and proteolysis in ER. 





Fig. 4. Effects of proteasc inhibitors on the proteolytic activity of 
ER-60 rxotease. Protein disulfide-isomerase tPD1) (A) or calrcticulin 
(CAL) ‘(B) was incubated without (lanes l-and-9 or with ERaO 
protease (lanes 2-5. IO and 1 I) in the abscncc (lanes 2 and IO) or 
presence of IO PM ALLN (lane 3). 10 PM ALLM (lane 4), 10 pM 
TLCK (lane S), IO yM TPCK (lane 6). 10 ,uM leupeptin (lane 7). IO 
,uM E-64 (lane 8) or 1 mM EGTA Jane 1 I) ~137% for 3 h (lanes l-8). 
10 min (A, lanes 9-1 I), or 20 mir! (B, lanes 9-1 I) as described under 
Experimental. Then the sa:nples were subjected to SDS-PAGE. 
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ing to proteolysis in ER to understand the inhibition of 
ER-60 protease by acidic phospholipids. 
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